- Home
- CARE vs CRVS Comparison
CARE vs CRVS Comparison
Compare CARE & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARE
- CRVS
- Stock Information
- Founded
- CARE 1974
- CRVS 2014
- Country
- CARE United States
- CRVS United States
- Employees
- CARE N/A
- CRVS N/A
- Industry
- CARE Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- CARE Finance
- CRVS Health Care
- Exchange
- CARE Nasdaq
- CRVS Nasdaq
- Market Cap
- CARE 456.8M
- CRVS 459.0M
- IPO Year
- CARE N/A
- CRVS 2016
- Fundamental
- Price
- CARE $17.08
- CRVS $8.04
- Analyst Decision
- CARE
- CRVS Strong Buy
- Analyst Count
- CARE 0
- CRVS 4
- Target Price
- CARE N/A
- CRVS $13.75
- AVG Volume (30 Days)
- CARE 103.1K
- CRVS 1.1M
- Earning Date
- CARE 10-23-2025
- CRVS 11-04-2025
- Dividend Yield
- CARE N/A
- CRVS N/A
- EPS Growth
- CARE 118.89
- CRVS N/A
- EPS
- CARE 1.36
- CRVS N/A
- Revenue
- CARE $154,517,000.00
- CRVS N/A
- Revenue This Year
- CARE $10.85
- CRVS N/A
- Revenue Next Year
- CARE $14.41
- CRVS N/A
- P/E Ratio
- CARE $12.56
- CRVS N/A
- Revenue Growth
- CARE 20.24
- CRVS N/A
- 52 Week Low
- CARE $13.61
- CRVS $2.54
- 52 Week High
- CARE $20.53
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- CARE 32.45
- CRVS 64.17
- Support Level
- CARE $17.70
- CRVS $7.46
- Resistance Level
- CARE $18.50
- CRVS $7.96
- Average True Range (ATR)
- CARE 0.62
- CRVS 0.56
- MACD
- CARE -0.19
- CRVS 0.01
- Stochastic Oscillator
- CARE 2.95
- CRVS 75.46
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).